Company intelligence / Profile preview

NeuroClin

Glasgow, Scotland, United Kingdomneuroclin.com ↗

Ownership: Private
Development stage: Commercial

Overview

NeuroClin operates as a specialized clinical research organization focused on conducting high-quality clinical trials in neurological and neuropsychiatric disorders. The company has established itself as a leading recruiting site for global Parkinson's disease studies and has expanded its portfolio to include Alzheimer's disease, depression, and migraine. NeuroClin collaborates with major pharmaceutical sponsors to execute protocol-driven research with an emphasis on patient support and data integrity.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Partnerships

Major pharmaceutical companies sponsoring global neurology/neuropsychiatry trials—not named specifically but described generally.

Beyond the preview

Go deeper on NeuroClin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroClin.

Explore the full profile